{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T11:54:24Z","timestamp":1776686064926,"version":"3.51.2"},"reference-count":38,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T00:00:00Z","timestamp":1653004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Constipation is one of the most common non-motor symptoms in multiple system atrophy (MSA); however, it has not been evaluated according to the standard diagnostic criteria for constipation in patients with MSA. We evaluated the characteristics of constipation in patients with MSA by using Rome criteria (Rome III), which has been validated and the widely used for gastrointestinal disorders. Fifty-one patients with MSA (29 female) were enrolled in the study. Based on the Rome III criteria, constipation was diagnosed in 29 patients (56.9%); irritable bowel syndrome was not detected. Thirty-seven patients (72.5%) were aware of their constipation. The most common constipation symptom was the sensation of anorectal obstruction (68.6%). Patients\u2019 self-awareness of constipation was most strongly correlated to the sensation of incomplete evacuation (odds ratio: 7.377, 95% confidence interval: 1.402\u201338.817). The number of constipation-related symptoms was correlated with the total levodopa equivalent dose (p &lt; 0.05). Rome criteria, which can detect various constipation symptoms, are useful for evaluating constipation in MSA, and these findings may greatly impact personalized medicine.<\/jats:p>","DOI":"10.3390\/jpm12050838","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T13:56:12Z","timestamp":1653054972000},"page":"838","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Constipation Symptoms in Multiple System Atrophy Using Rome Criteria and Their Impact on Personalized Medicine"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4649-0434","authenticated-orcid":false,"given":"Takayasu","family":"Mishima","sequence":"first","affiliation":[{"name":"Department of Neurology, School of Medicine, Fukuoka University, Fukuoka 814-0180, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinsuke","family":"Fujioka","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine, Fukuoka University, Fukuoka 814-0180, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miki","family":"Kawazoe","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Public Health, School of Medicine, Fukuoka University, Fukuoka 814-0180, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kotoe","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine, Fukuoka University, Fukuoka 814-0180, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2064-2014","authenticated-orcid":false,"given":"Hisatomi","family":"Arima","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Public Health, School of Medicine, Fukuoka University, Fukuoka 814-0180, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6758-0981","authenticated-orcid":false,"given":"Yoshio","family":"Tsuboi","sequence":"additional","affiliation":[{"name":"Department of Neurology, School of Medicine, Fukuoka University, Fukuoka 814-0180, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/jnnp.74.1.13","article-title":"Constipation in neurological diseases","volume":"74","author":"Winge","year":"2003","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.parkreldis.2015.10.011","article-title":"Gastric motor dysfunctions in Parkinson\u2019s disease: Current pre-clinical evidence","volume":"21","author":"Pellegrini","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/14656566.2020.1726319","article-title":"The pharmacological management of constipation in patients with Parkinson\u2019s disease: A much-needed relief","volume":"21","author":"Mozaffari","year":"2020","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3233\/JPD-160982","article-title":"The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson\u2019s Disease Patients According to Rome III Diagnostic Criteria","volume":"7","author":"Mishima","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1443-9573.2006.00265.x","article-title":"Rome III: The new criteria","volume":"7","author":"Drossman","year":"2006","journal-title":"Chin. J. Dig. Dis."},{"key":"ref_6","first-page":"237","article-title":"Rome III: New standard for functional gastrointestinal disorders","volume":"15","author":"Drossman","year":"2006","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/mds.27344","article-title":"Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies","volume":"33","author":"Palma","year":"2018","journal-title":"Mov. Disord."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"7","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/jnnp-2017-315813","article-title":"Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy","volume":"89","author":"Koga","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"100369","DOI":"10.1016\/j.ensci.2021.100369","article-title":"Circulatory 25(OH)D and 1,25(OH) 2 D as differential biomarkers between multiple system atrophy and Parkinson\u2019s disease patients","volume":"25","author":"Ogura","year":"2021","journal-title":"eNeurologicalSci"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1055\/s-2008-1040982","article-title":"Gastrointestinal dysfunction in multiple system atrophy","volume":"16","author":"Mathias","year":"1996","journal-title":"Semin. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/nau.22764","article-title":"A guideline for the management of bladder dysfunction in Parkinson\u2019s disease and other gait disorders","volume":"35","author":"Sakakibara","year":"2016","journal-title":"Neurourol. Urodyn."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1007\/s10072-021-05411-y","article-title":"Lower urinary tract dysfunction in Parkinsonian syndromes","volume":"42","author":"Vichayanrat","year":"2021","journal-title":"Neurol. Sci."},{"key":"ref_14","unstructured":"Fukudo, S., Hongo, M., and Matsueda, K. (2008). Rome III: The Functional Gastrointestinal Disorders: Japanese Version, KYOWA KIKAKU."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.parkreldis.2015.02.005","article-title":"Characterization of gastrointestinal disorders in patients with parkinsonian syndromes","volume":"21","author":"Park","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/mds.22187","article-title":"Autonomic dysfunction in different subtypes of multiple system atrophy","volume":"23","author":"Schmidt","year":"2008","journal-title":"Mov. Disord."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/mds.20165","article-title":"Colonic transit time, sphincter EMG, and rectoanal videomanometry in multiple system atrophy","volume":"19","author":"Sakakibara","year":"2004","journal-title":"Mov. Disord."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s10072-021-05041-4","article-title":"Gastrointestinal dysfunction in movement disorders","volume":"42","author":"Sakakibara","year":"2021","journal-title":"Neurol. Sci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"720958","DOI":"10.3389\/fneur.2021.720958","article-title":"Association between irritable bowel syndrome and risk of Parkinson\u2019s Disease: A systematic review and meta-analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Lu, S., Jiang, H.Y., and Shi, Y.D. Association between irritable bowel syndrome and Parkinson\u2019s disease: A systematic review and meta-analysis. Acta Neurol. Scand., 2021. in press.","DOI":"10.1111\/ane.13570"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2169\/internalmedicine.4836-20","article-title":"Effectiveness of Levodopa in Patients with Multiple System Atrophy and Associated Clinicopathological Features","volume":"60","author":"Ishida","year":"2021","journal-title":"Intern. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1523\/JNEUROSCI.4720-05.2006","article-title":"Physiological modulation of intestinal motility by enteric dopaminergic neurons and the D2 receptor: Analysis of dopamine receptor expression, location, development, and function in wild-type and knock-out mice","volume":"26","author":"Li","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/mds.28119","article-title":"Meta-Analysis of Gut Dysbiosis in Parkinson\u2019s Disease","volume":"35","author":"Nishiwaki","year":"2020","journal-title":"Mov. Disord."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","article-title":"Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation","volume":"7","author":"Romano","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"636545","DOI":"10.3389\/fnagi.2021.636545","article-title":"The Association Between the Gut Microbiota and Parkinson\u2019s Disease, a Meta-Analysis","volume":"13","author":"Shen","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2021.11.017","article-title":"Gut microbiome in Parkinson\u2019s disease: New insights from meta-analysis","volume":"94","author":"Toh","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"12693","DOI":"10.1038\/srep12693","article-title":"Reduction of butyrate- and methane-producing microorganisms in patients with Irritable bowel syndrome","volume":"5","author":"Pozuelo","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_29","first-page":"512","article-title":"Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome","volume":"22","author":"Tana","year":"2010","journal-title":"Neurogastroenterol. Motil."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1212\/WNL.57.3.456","article-title":"Frequency of bowel movements and the future risk of Parkinson\u2019s disease","volume":"57","author":"Abbott","year":"2001","journal-title":"Neurology"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00415-004-1706-3","article-title":"Life style risks of Parkinson\u2019s disease: Association between decreased water intake and constipation","volume":"251","author":"Ueki","year":"2004","journal-title":"J. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/00002826-199210000-00004","article-title":"Clinical and pharmacokinetic effects of a diet rich in insoluble fiber on Parkinson disease","volume":"15","author":"Astarloa","year":"1992","journal-title":"Clin. Neuropharmacol."},{"key":"ref_33","first-page":"117","article-title":"Use of probiotics for the treatment of constipation in Parkinson\u2019s disease patients","volume":"57","author":"Cassani","year":"2011","journal-title":"Minerva Gastroenterol. Dietol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.parkreldis.2014.11.015","article-title":"Constipation is reduced by beta-blockers and increased by dopaminergic medications in Parkinson\u2019s disease","volume":"21","author":"Pagano","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10654-014-9878-3","article-title":"Irritable bowel syndrome correlates with increased risk of Parkinson\u2019s disease in Taiwan","volume":"29","author":"Lai","year":"2014","journal-title":"Eur. J. Epidemiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00702-007-0855-9","article-title":"Bladder and bowel dysfunction in Parkinson\u2019s disease","volume":"115","author":"Sakakibara","year":"2008","journal-title":"J. Neural Transm."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11894-017-0554-0","article-title":"Update on Rome IV Criteria for Colorectal Disorders: Implications for Clinical Practice","volume":"19","author":"Simren","year":"2017","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.parkreldis.2016.12.007","article-title":"Non-motor symptoms and the quality of life in multiple system atrophy with different subtypes","volume":"35","author":"Zhang","year":"2017","journal-title":"Parkinsonism Relat. Disord."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/12\/5\/838\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:15:26Z","timestamp":1760138126000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/12\/5\/838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,20]]},"references-count":38,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["jpm12050838"],"URL":"https:\/\/doi.org\/10.3390\/jpm12050838","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,20]]}}}